Intersect Capital’s Mandiant, Inc. Common Stock MNDT Stock Holding History

Intersect Capital’s Portfolio MNDT Stock Details MNDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-260	Closed	-$11K	–	394
2015 Q1	$11K	Hold	260	–	–	0.01%	322
2014 Q4	$8K	Buy	+260	New	+$7.98K	0.01%	363

Other funds holding MNDT

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SIM

SRS Investment Management New York $10.8B AUM 34.05% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Intersect Capital's MNDT Position: Q2 2015 in Review

Intersect Capital sold out of Mandiant, Inc. Common Stock (MNDT) in Q2 2015, closing a stake of 260 shares — an estimated $11K sold.

Intersect Capital first reported a position in MNDT in Q4 2014 and held it in 2 quarters. The position peaked at $11K in Q1 2015. 396 funds tracked by Wall St. Rank hold MNDT as of Q2 2015.

Intersect Capital reported no remaining Mandiant, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
Intersect Capital sold 260 Mandiant, Inc. Common Stock shares in Q2 2015, an estimated $11K.
Intersect Capital first reported a position in Mandiant, Inc. Common Stock in Q4 2014 and held it in 2 quarters.
Intersect Capital's Mandiant, Inc. Common Stock position peaked at $11K in Q1 2015.
396 funds tracked by Wall St. Rank held Mandiant, Inc. Common Stock as of Q2 2015.

Based on Intersect Capital's 13F filing for Q2 2015, filed 3 Aug 2015.